Shopping Cart
- Remove All
Your shopping cart is currently empty
CBP/p300ligand 4 (Compound 4) is an orally active inhibitor of the CBP/p300 bromodomain, with an IC50 of 91.4 nM. It serves as the target protein ligand for PROTACXYD190.

| Description | CBP/p300ligand 4 (Compound 4) is an orally active inhibitor of the CBP/p300 bromodomain, with an IC50 of 91.4 nM. It serves as the target protein ligand for PROTACXYD190. |
| In vitro | CBP/p300 ligand 4 (0-1 μM, 72-120 h) inhibits proliferation in AML cell lines MV4;11, MOLM-13, and MOLM-16 by degrading CBP, p300, and c-Myc proteins, with IC 50 values of 20.4, 102, and 12.9 nM, respectively. |
| In vivo | The compound CBP/p300 ligand 4, when administered orally at a dosage of 10 mg/kg once daily for two weeks, demonstrated antitumor activity in the MV4;11 xenograft mouse model, achieving a tumor growth inhibition (TGI) rate of 65%. |
| Formula | C30H31F2N5O4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.